Can we treat bladder cancer with intravesical Bacillus Calmette-Guerin in patients with prior tuberculosis infection? A population-based cohort study

BACKGROUND: Intravesical bacillus Calmette-Guerin (BCG) therapy is the treatment of choice for patients with T1 or high-grade superficial bladder cancer or those with carcinoma in situ after transurethral resection. A personal history of tuberculosis infection has been viewed as a relative contraind...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsu, Che-Wei, Chiu, Yi-Chun, Hu, Hsiao-Yun, Fan, Yu-Hua, Hong, Shih-Chi, Cheng, Wei-Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7346498/
https://www.ncbi.nlm.nih.gov/pubmed/32641099
http://dx.doi.org/10.1186/s12894-020-00642-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7346498/
https://www.ncbi.nlm.nih.gov/pubmed/32641099
http://dx.doi.org/10.1186/s12894-020-00642-1

Ejemplares similares